Study Subjects | Positivity for CHIKV Antigen (%) | Negativity for CHIKV Antigen (%) |
---|---|---|
Neuro-CHIKV patients (n = 46) | 37 (80%) | 9 (20%) |
Confirmed (n = 9) | 9 (100%) | 0 |
   Encephalitis (n = 4) | 4 (100%) | 0 |
   Myelopathy (n = 2) | 2 (100%) | 0 |
   Myeloneuropathy (n = 1) | 1 (100%) | 0 |
   Peripheral Neuropathy (n = 1) | 1 (100%) | 0 |
   Myopathy (n = 1) | 1 (100%) | 0 |
Suspected (n = 37) | 28 (76%) | 9 (24%) |
   Encephlitis (n = 20) | 16 (80%) | 4 (20%) |
   Myelopathy (n = 5) | 5 (100%) | 0 |
   Myeloneuropathy (n = 6) | 4 (67%) | 2 (33%) |
   Peripheral Neuropathy (n = 6) | 3 (50%) | 3 (50%) |
Non-CHIKV patients (n = 15) | 2 (13%) | 13 (87%) |